Lipoxin A4 and lipoxin A4 receptor expression in induced sputum of asthmatic children
R. Gagliardo, P. Chanez, F. Pompeo, S. La Grutta, L. Siena, M. Profita, A. Bonanno, C. Bonnans, I. Vachier, G. Bonsignore, M. Gjomarkaj (Palermo, Italy; Montpellier, France)
Source: Annual Congress 2007 - New mechanisms in the pathogenesis of asthma and allergy
Session: New mechanisms in the pathogenesis of asthma and allergy
Session type: Electronic Poster Discussion
Number: 1673
Disease area: Airway diseases
Rating:
You must login to grade this presentation.
Share or cite this content
Citations should be made in the following way:
R. Gagliardo, P. Chanez, F. Pompeo, S. La Grutta, L. Siena, M. Profita, A. Bonanno, C. Bonnans, I. Vachier, G. Bonsignore, M. Gjomarkaj (Palermo, Italy; Montpellier, France). Lipoxin A4 and lipoxin A4 receptor expression in induced sputum of asthmatic children. Eur Respir J 2007; 30: Suppl. 51, 1673
You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
Related content which might interest you:
Related content which might interest you:
Role of lipoxin A4 in induced sputum of asthmatic children Source: Annual Congress 2008 - Invasive and noninvasive measurements of lung inflammation Year: 2008
Lipoxin A4 receptor expression in smokers with and without COPD Source: Annual Congress 2011 - Novel mechanisms in lung injury Year: 2011
Anti-inflammatory effect of Lipoxin A4 (LXA4) on human bronchial epithelial cells Source: Eur Respir J 2002; 20: Suppl. 38, 619s Year: 2002
Lipoxin A4 regulates bronchial epithelium responses to acid injury Source: Eur Respir J 2006; 28: Suppl. 50, 660s Year: 2006
Chronic obstructive pulmonary disease is characterized with suppressed lipoxin A4 and increased lipoxin receptor expression in lungs Source: Annual Congress 2012 - The smoking gun in COPD biology Year: 2012
Quantitative assessment of cysteinyl leukotrienes in human sputum during the allergen-induced asthmatic response and the effect of GSK2190915, a 5-lipoxygenase activating protein (FLAP) inhibitor Source: Annual Congress 2011 - Diagnosis and treatment of inflammatory respiratory diseases Year: 2011
Leukotriene B4 levels in sputum from asthma patients Source: ERJ Open Res, 2 (4) 00088-2015; 10.1183/23120541.00088-2015 Year: 2016
Upregulation of cysteinyl leukotriene receptors CysLT1 and CysLT2 by TGF-β1 and LTE4 on human bronchial epithelial cells Source: Annual Congress 2006 - Airway epithelial cells in inflammation Year: 2006
Increased leukotriene and lower prostaglandin E2 concentrations in induced sputum of patients with eosinophilic asthma Source: Eur Respir J 2005; 26: Suppl. 49, 733s Year: 2005
The CysLT1 receptor antagonist montelukast inhibits mast cell activation induced by inhaled leukotriene E4 in subjects with asthma Source: International Congress 2016 – Clinical and molecular studies in asthma Year: 2016
Expression of the cysteinyl leukotriene receptors cysLT1 and cysLT2 in the airway structural cells Source: Eur Respir J 2005; 26: Suppl. 49, 346s Year: 2005
Reduced 15-lipoxygenase 2 and lipoxin A4/leukotriene B4 ratio in children with cystic fibrosis Source: Eur Respir J 2014; 44: 394-404 Year: 2014
Increased expression of the cysteinil leukotriene 1 receptor (CysLT1-R) in the bronchial epithelium of smokers Source: Eur Respir J 2001; 18: Suppl. 33, 74s Year: 2001
The pro-apoptotic effect of cysteinyl leukotriene receptor (CysLT-R) antagonist montelukast is mediated by CysLT-Rs expression on antigen-stimulated T cells Source: Eur Respir J 2003; 22: Suppl. 45, 100s Year: 2003
Intranasal administration of leukotriene B4 selectively increases human nasal neutrophil activity Source: Annual Congress 2008 - Phenotyping of asthma and COPD Year: 2008
Leukotriene C4 synthase polymorphism does not associate with clinical response to leukotriene receptor antagonists in persistent asthma Source: Eur Respir J 2002; 20: Suppl. 38, 303s Year: 2002
Leukotriene B4 receptor blockade increases apoptosis of monocyte-derived macrophages from patients with COPD and emphysema Source: Eur Respir J 2001; 18: Suppl. 33, 337s Year: 2001
Lipoxin and eotaxin as markers of severity in patients with bronchial asthma Source: Annual Congress 2008 - Risk factors for allergic asthma and allergic rhinitis Year: 2008
The effects of a cysteinyl leukotriene receptor antagonist, pranlukast, on dendritic cell chemoattractants in the airways of subjects with asthma Source: Eur Respir J 2004; 24: Suppl. 48, 132s Year: 2004
Downregulation of prostaglandin E2 in bronchial fibroblasts of asthmatic patients Source: Eur Respir J 2002; 20: Suppl. 38, 95s Year: 2002